Literature DB >> 8986816

Definition of HLA-DQ as a transplantation antigen.

E W Petersdorf1, G M Longton, C Anasetti, E M Mickelson, A G Smith, P J Martin, J A Hansen.   

Abstract

Recent studies have demonstrated the importance of recipient HLA-DRB1 allele disparity in the development of acute graft-versus-host disease (GVHD) after unrelated donor marrow transplantation. The role of HLA-DQB1 allele disparity in this clinical setting is unknown. To elucidate the biological importance of HLA-DQB1, we conducted a retrospective analysis of 449 HLA-A, -B, and -DR serologically matched unrelated donor transplants. Molecular typing of HLA-DRB1 and HLA-DQB1 alleles revealed 335 DRB1 and DQB1 matched pairs; 41 DRB1 matched and DQB1 mismatched pairs; 48 DRB1 mismatched and DQB1 matched pairs; and 25 DRB1 and DQB1 mismatched pairs. The conditional probabilities of grades III-IV acute GVHD were 0.42, 0.61, 0.55, and 0.71, respectively. The relative risk of acute GVHD associated with a single locus HLA-DQB1 mismatch was 1.8 (1.1, 2.7; P = 0.01), and the risk associated with any HLA-DQB1 and/or HLA-DRB1 mismatch was 1.6 (1.2, 2.2; P = 0.003). These results provide evidence that HLA-DQ is a transplant antigen and suggest that evaluation of both HLA-DQB1 and HLA-DRB1 is necessary in selecting potential donors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8986816      PMCID: PMC26409          DOI: 10.1073/pnas.93.26.15358

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

Review 1.  Bone-marrow transplantation (second of two parts).

Authors:  E D Thomas; R Storb; R A Clift; A Fefer; L Johnson; P E Neiman; K G Lerner; H Glucksberg; C D Buckner
Journal:  N Engl J Med       Date:  1975-04-24       Impact factor: 91.245

2.  Linkage disequilibrium in HLA cannot be explained by selective recombination.

Authors:  A Termijtelen; J D'Amaro; J J van Rood; G M Schreuder
Journal:  Tissue Antigens       Date:  1995-11

3.  Allelic frequencies of the HLA-B17 antigen group: comparative analysis by serology, IEF and PCR-SSOP typing.

Authors:  J E Levine; S Y Yang
Journal:  Tissue Antigens       Date:  1995-11

4.  Identification of an HLA-DR-associated system of B-cell alloantigens.

Authors:  R J Duquesnoy; M Marrari; K Annen
Journal:  Transplant Proc       Date:  1979-12       Impact factor: 1.066

5.  Large-scale DRB and DQB1 oligonucleotide typing for the NMDP registry: progress report from year 2.

Authors:  J Ng; C K Hurley; C Carter; L A Baxter-Lowe; D Bing; M Chopek; J Hegland; T D Lee; T C Li; S Hsu; D KuKuruga; J M Mason; D Monos; H Noreen; G Rosner; B Schmeckpeper; B Dupont; R J Hartzman
Journal:  Tissue Antigens       Date:  1996-01

6.  Major histocompatibility antigens: the human (HLA-A, -B, -C) and murine (H-2K, H-2D) class I molecules.

Authors:  H L Ploegh; H T Orr; J L Strominger
Journal:  Cell       Date:  1981-05       Impact factor: 41.582

7.  Evidence for two series of B-cell antigens in man and their comparison with HLA-D.

Authors:  J J van Rood; A van Leeuwen; J J Keuning; A Termijtelen
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

8.  Histocompatible unrelated volunteer donors compared with HLA nonidentical family donors in marrow transplantation for aplastic anemia and leukemia.

Authors:  J M Hows; J L Yin; J Marsh; D Swirsky; L Jones; J F Apperley; D C James; S Smithers; J R Batchelor; J M Goldman
Journal:  Blood       Date:  1986-12       Impact factor: 22.113

9.  Association of MB compatibility with successful intrafamilial kidney transplantation.

Authors:  R J Duquesnoy; K B Annen; M M Marrari; H M Kauffman
Journal:  N Engl J Med       Date:  1980-04-10       Impact factor: 91.245

10.  Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia.

Authors:  R Storb; H J Deeg; J Whitehead; F Appelbaum; P Beatty; W Bensinger; C D Buckner; R Clift; K Doney; V Farewell
Journal:  N Engl J Med       Date:  1986-03-20       Impact factor: 91.245

View more
  11 in total

Review 1.  Genetics of graft-versus-host disease: the major histocompatibility complex.

Authors:  Effie W Petersdorf
Journal:  Blood Rev       Date:  2012-11-20       Impact factor: 8.250

2.  HLA and cross-reactive antigen group matching for cadaver kidney allocation.

Authors:  T E Starzl; M Eliasziw; D Gjertson; P I Terasaki; J J Fung; M Trucco; J Martell; J McMichael; V Scantlebury; R Shapiro; A Donner
Journal:  Transplantation       Date:  1997-10-15       Impact factor: 4.939

3.  Early decrease in surface expression of HLA-DQ predicts the development of infection in trauma patients.

Authors:  J V Taylor; L E Gordon; H C Polk
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

4.  Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival.

Authors:  Daniel Weisdorf; Stephen Spellman; Michael Haagenson; Mary Horowitz; Stephanie Lee; Claudio Anasetti; Michelle Setterholm; Rebecca Drexler; Martin Maiers; Roberta King; Dennis Confer; John Klein
Journal:  Biol Blood Marrow Transplant       Date:  2008-07       Impact factor: 5.742

5.  Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.

Authors:  Joseph Pidala; Stephanie J Lee; Kwang Woo Ahn; Stephen Spellman; Hai-Lin Wang; Mahmoud Aljurf; Medhat Askar; Jason Dehn; Marcelo Fernandez Viña; Alois Gratwohl; Vikas Gupta; Rabi Hanna; Mary M Horowitz; Carolyn K Hurley; Yoshihiro Inamoto; Adetola A Kassim; Taiga Nishihori; Carlheinz Mueller; Machteld Oudshoorn; Effie W Petersdorf; Vinod Prasad; James Robinson; Wael Saber; Kirk R Schultz; Bronwen Shaw; Jan Storek; William A Wood; Ann E Woolfrey; Claudio Anasetti
Journal:  Blood       Date:  2014-08-26       Impact factor: 22.113

6.  Effect of nonpermissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T-cell depletion.

Authors:  Betül Oran; Rima M Saliba; Yudith Carmazzi; Marcos de Lima; Gabriela Rondon; Sairah Ahmed; Amin Alousi; Borje S Andersson; Paolo Anderlini; Michelle Alvarez; Qasier Bashir; Stefan Ciurea; Marcelo Fernandez-Vina; Chitra Hosing; Partow Kebriaei; Martin Korbling; Pedro Cano; Issa Khouri; David Marin; Yago Nieto; Amanda Olson; Uday Popat; Katy Rezvani; Muzaffar Qazilbash; Elizabeth J Shpall; Richard E Champlin; Kai Cao
Journal:  Blood       Date:  2018-01-31       Impact factor: 22.113

7.  HLA-DQ Mismatches and Rejection in Kidney Transplant Recipients.

Authors:  Wai H Lim; Jeremy R Chapman; Patrick T Coates; Joshua R Lewis; Graeme R Russ; Narelle Watson; Rhonda Holdsworth; Germaine Wong
Journal:  Clin J Am Soc Nephrol       Date:  2016-03-31       Impact factor: 8.237

8.  HLA-A disparities illustrate challenges for ranking the impact of HLA mismatches on bone marrow transplant outcomes in the United States.

Authors:  Lee Ann Baxter-Lowe; Martin Maiers; Stephen R Spellman; Michael D Haagenson; Tao Wang; Marcelo Fernandez-Vina; Steven G E Marsh; Mary Horowitz; Carolyn Katovich Hurley
Journal:  Biol Blood Marrow Transplant       Date:  2009-08       Impact factor: 5.742

9.  The value of high-resolution HLA in the perioperative period of non-sensitized lung transplant recipients.

Authors:  Ji Zhang; Dong Liu; Caixin Zhang; Min Zhou; Jian Lv; Hongmei Wang; Hang Yang; Li Fan; Bo Wu; Jingyu Chen
Journal:  Ann Transl Med       Date:  2020-02

10.  Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation From Unrelated Donor Using Tacrolimus/Sirolimus-based GvHD Prophylaxis: Impact of HLA Mismatch.

Authors:  Monzr M Al Malki; Ketevan Gendzekhadze; Dongyun Yang; Sally Mokhtari; Pablo Parker; Chatchada Karanes; Joycelynne Palmer; David Snyder; Stephen J Forman; Auayporn Nademanee; Ryotaro Nakamura
Journal:  Transplantation       Date:  2020-05       Impact factor: 5.385

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.